Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma.

Autor: Park, Byeong-Bae¹ (AUTHOR), Kim, Jin Seok² (AUTHOR), Lee, Young-Yuel¹ (AUTHOR), Kang, Hye Jin³ (AUTHOR), Ryoo, Baek Yeol³ (AUTHOR), Kang, Jung Hun⁴ (AUTHOR), Kim, Ho Young⁵ (AUTHOR), Kim, Bong-Seog⁶ (AUTHOR), Oh, Sung Yong⁷ (AUTHOR), Kwon, Hyuk Chan⁷ (AUTHOR), Won, Jong Ho⁸ (AUTHOR), Kim, Kihyun⁹ (AUTHOR), Park, Keunchil⁹ (AUTHOR), Suh, Cheolwon¹⁰ (AUTHOR), Kim, Won Seog⁹ (AUTHOR) wskimsmc@smc.samsung.co.kr

Publikováno v: Leukemia & Lymphoma. Jan2008, Vol. 49 Issue 1, p88-94. 7p. 3 Charts, 1 Graph.

Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study.

Autor: Kang, Hye, Kim, Won, Kim, Seok, Lee, Je-Jung, Yang, Deok-Hwan, Kim, Jin, Lee, Se-Ryeon, Lee, Gyeong-Won, Kim, Hyo, Kim, Ho, Oh, Sung, Kim, Hugh, Eom, Hyeon-Seok, Chung, Jooseop, Park, Jinny, Suh, Cheolwon, Ryoo, Baek-Yeol

Publikováno v: Annals of Hematology; Apr2012, Vol. 91 Issue 4, p543-551, 9p, 4 Charts, 1 Graph

Pulmonary marginal zone B-cell lymphoma of MALT type-What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) Study.

Autor: Oh, Sung, Kim, Won, Kim, Jin, Kim, Seok, Kwon, Hyuk-Chan, Lee, Dae, Won, Jong, Hwang, In, Kim, Min, Lee, Soon, Chae, Yee, Yang, Deok-Hwan, Lee, Gyeong-Won, Choi, Chul, Park, Jinny, Suh, Cheolwon, Kim, Hyo-Jin

Publikováno v: Annals of Hematology; Jun2010, Vol. 89 Issue 6, p563-568, 6p